![]() |
Positive safety data from BioSante's ongoing LibiGel Phase III study for HSDD treatme
BioSante Pharmaceuticals, today announced positive safety data in its ongoing LibiGel Phase III clinical development program.
More... |
| All times are GMT -7. The time now is 02:44 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021